sulfinpyrazone (Anturane)
Jump to navigation
Jump to search
Introduction
Tradename: Anturane.
Indications
Contraindications
Dosage
Tabs: 100 & 200 mg.
Adverse effects
- common (> 10%)
- less common (1-10%)
- uncommon (< 1%)
- flushing, dizziness, headache, rash, anemia, leukopenia, increased bleeding time (decreased platelet aggregation), hepatic necrosis, urinary frequency, uric acid stones, nephrotic syndrome
Mechanism of action
More general terms
Additional terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Deprecated Reference
- ↑ 4.0 4.1 Khanna D et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012 Oct; 64:1431 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23024028
Pui K et al. Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population. J Rheumatol 2013 Jun; 40:872. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23457380